Skip to main content

Table 4 Barriers to ethical promotion of pharmaceuticals in Pakistan; MR’s perspective

From: Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors

Questions on barriers in ethical promotion

Medical representatives (MRs) (5-point Likert score)

p values

NCs, n = 205 (Mean ± SD)

MNCs, n = 125 (Mean ± SD)

Lack of external accountability can be a reason of unethical practices

3.66 ± 1.33

4.17 ± 1.1

0.0003*

Doctors are incentivized to generate business by undue investigation and overtreatment of patients who are at their mercy, medically and financially

3.56 ± 1.23

3.82 ± 1.26

0.077

Price war in Pharmaceuticals

3.73 ± 1.26

4.18 ± 0.97

0.0007**

To maximize the profit

3.83 ± 1.19

4.22 ± 0.99

0.003*

Lack of Research and Study

3.62 ± 1.33

4.28 ± 0.96

0.0001**

Company pressure to achieve sale targets

3.88 ± 1.24

4.02 ± 1.21

0.318

Low quality products need unethical push

3.67 ± 1.35

4.38 ± 0.96

0.0001**

Job insecurity if sales below target

3.61 ± 1.34

4 ± 1.19

0.008*

Non-existence of Doctor-Patient-Pharmacist Loop

3.55 ± 1.27

3.98 ± 1.11

0.003*

Prescribing by Brand names

3.8 ± 1.23

4. ± 1.11

0.097

Doctors are materialistic lacking ethical and moral values

3.57 ± 1.2

3.88 ± 1.26

0.033*

Sales managers not only condone unethical promotions of MRs but also encourage it

3.31 ± 1.34

3.75 ± 1.28

0.003**

Low salaries, thus for incentives, MRs opt un-ethical promotion

3.57 ± 1.23

3.96 ± 1.22

0.006*

Junior doctors use Pharma companies to promote their business (clinic renovation, foreign trips) and clinical practice (speakers at the seminar, free camps)

3.94 ± 1.14

3.98 ± 1.17

0.747

  1. MNCs multinational companies, NCs national companies, MR medical representative (s)
  2. p values: p 0.05–0.002 = *, p ≤ 0.001 = **